Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Revenue

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,360 Cr₹7,845 Cr₹7,767 Cr₹8,960 Cr₹6,969 Cr

What is the latest Revenue of DIVIS LABORATORIES ?

The latest Revenue ratio of DIVIS LABORATORIES is ₹9,360 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,360 Cr
Mar2024₹7,845 Cr
Mar2023₹7,767 Cr
Mar2022₹8,960 Cr
Mar2021₹6,969 Cr

How is Revenue of DIVIS LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹9,360 Cr
19.31
Mar2024 ₹7,845 Cr
1.00
Mar2023 ₹7,767 Cr
-13.31
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr -

Compare Revenue of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹159,643.8 Cr 0.6% -4.5% 3.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics
MANKIND PHARMA ₹83,401.6 Cr 1% -1.3% -11.5% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

0.6%

-4.5%

3.4%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses